InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,953.25
(
0.62%
)

Replies to post #2925 on InMed Pharmaceuticals Inc (INM)

Replies to #2925 on InMed Pharmaceuticals Inc (INM)

Vinpat

06/07/17 4:50 PM

#2926 RE: Mandofellow #2925

They won't be ready to start trials on their EB drug for at least a year and more likely 18 months. Glaucoma is out further than that. Any news would come from Bioinformatics or Biosynthesis if they have value.